1-2 of 2
Tim Kong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

Clinical Trials & Observations
Stephen T. Oh, Ruben A. Mesa, Claire N. Harrison, Prithviraj Bose, Aaron T. Gerds, Vikas Gupta, Bart L. Scott, Jean-Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah A. Buckley, Shanthakumar Tyavanagimatt, Bryan G. Harder, Karisse Roman-Torres, Jennifer Smith, Adam R. Craig, John Mascarenhas, Srdan Verstovsek
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5835–5842.
https://doi.org/10.1182/bloodadvances.2023010151
Published: 2023
Includes: Supplemental data
Journal Articles

Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition

Tim Kong, Angelo B.A. Laranjeira, Taylor B. Collins, Elisa S. De Togni, Abigail J. Wong, Mary C. Fulbright, Marianna Ruzinova, Hamza Celik, Grant A. Challen, Daniel A.C. Fisher, Stephen T. Oh
Journal: Blood Advances
Blood Adv (2022) 6 (2): 611–623.
https://doi.org/10.1182/bloodadvances.2020002804
Published: 2022
Includes: Supplemental data